Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: PLD|DRUG: CTX|DRUG: Docetaxel|DRUG: Paclitaxel|DRUG: Doxorubicin
Sponsor: Fudan University